Legal & General Group PLC Cue Biopharma, Inc. Transaction History

Legal & General Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.11 - $4.91 $13,093 - $20,671	4,210 New	4,210 $15,000
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $5,447 - $8,232	-2,443 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$2.49 - $5.92 $53,542 - $127,297	-21,503 Reduced 89.8%	2,443 $6,000
Q4 2021 Feb 14, 2022	BUY	$10.86 - $17.85 $102,507 - $168,486	9,439 Added 65.07%	23,946 $270,000
Q3 2021 Nov 15, 2021	BUY	$10.06 - $15.3 $54,132 - $82,329	5,381 Added 58.96%	14,507 $211,000
Q2 2021 Aug 12, 2021	SELL	$10.9 - $14.53 $3,956 - $5,274	-363 Reduced 3.83%	9,126 $106,000
Q1 2021 May 17, 2021	BUY	$11.2 - $16.09 $2,128 - $3,057	190 Added 2.04%	9,489 $115,000
Q3 2020 Nov 13, 2020	SELL	$15.05 - $23.54 $17,202 - $26,906	-1,143 Reduced 10.95%	9,299 $140,000
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $93,027 - $225,097	7,325 Added 235.0%	10,442 $256,000
Q1 2020 May 14, 2020	SELL	$9.85 - $22.27 $11,307 - $25,565	-1,148 Reduced 26.92%	3,117 $44,000
Q4 2019 Feb 13, 2020	BUY	$7.06 - $17.47 $5,210 - $12,892	738 Added 20.92%	4,265 $68,000
Q3 2019 Nov 13, 2019	BUY	$6.78 - $9.28 $6,095 - $8,342	899 Added 34.21%	3,527 $30,000
Q2 2018 Aug 10, 2018	BUY	$10.93 - $14.48 $11,684 - $15,479	1,069 Added 68.57%	2,628 $31,000
Q1 2018 May 17, 2018	BUY	$11.63 - $17.25 $18,131 - $26,892	1,559 New	1,559 $22,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.